Capnography, the monitoring of carbon dioxide (CO2) levels in exhaled breath, is an essential diagnostic tool used in healthcare settings to assess respiratory function. As respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea continue to rise globally, the demand for capnography equipment is expected to grow. These devices are critical for continuous monitoring during surgeries, intensive care, and emergency procedures, ensuring timely intervention and optimal patient care.
Furthermore, advancements in capnography technology, such as portable and non-invasive devices, are making these systems more accessible and versatile. The increasing adoption of capnography in various clinical settings, including hospitals, ambulatory surgical centers, and home healthcare, is expected to further drive market growth.
Click Here to Access More Insights on this Market, Get A Sample Report: https://www.fmisamplereport.com/sample/rep-gb-14367
Key Takeaways:
- The global capnography equipment market is projected to grow from USD 334 million in 2021 to USD 536.35 million by 2032, at a CAGR of 4.4%.
- The rising prevalence of respiratory disorders and diseases is driving demand for continuous monitoring and capnography solutions.
- Advancements in technology, including portable and non-invasive devices, are enhancing accessibility and adoption across clinical settings.
- The growing focus on patient safety and improved respiratory care is expected to further fuel market growth.
The market is supported by:
- The rise in respiratory diseases and ailments
- A growing number of healthcare facilities in emerging economies
- Supportive government initiatives across various countries
- Ongoing diversification in product portfolios
- An increasing number of cardiac and cardiopulmonary surgeries
- Outstanding customer and employee experience
- Revenue, profit growth, and business model innovation
Demand for capnography equipment is expected to positively drive the market over the forecast period owing to the focus on extensive Research and Development by manufacturers to support the healthcare sector with prominent offerings like technological advancements in the development of portable capnography monitors.
How can the Competitive Landscape Affect the Key Players of the Global Capnography Equipment Market?
Some of the key market players critical players in the capnography equipment market covered by the market analysis report are Koninklijke Philips N.V., Drägerwerk AG & Co.
KGAA., Nihon Kohden Corporation, Zoll Medical (Asahi Kasei Corporation), Edan Instruments, Inc., Hamilton Medical, Masimo Corporation, Monday DS USA, Inc., Nonna Medical, Inc., Schiller, Smiths Medical, Advantech, and BPL Medical Technologies.
Besides manufacturing and selling portable capnography monitors, major players in the market focus on providing customer solutions for better management and patient safety.
Such expansion in services provided by capnography equipment manufacturers has emerged to be the primary strategy adopted to remain competitive in today’s world.
Research & development activities also carried out by the investment of such players are also driving the demand for their products.
Some of the Recent Developments in the Capnography Equipment Market
- ZOLL Medical Corporation, a subsidiary of Asahi Kasei Company, acquired a medical device manufacturer in Israel named Itamar Medical Ltd. (Itamar Medical) in December 2021.
- Masimo Corporation and Philips N.V. signed an agreement in May 2020 to integrate Masimo NomoLine Capnography and O3 Regional Oximetry in some selected Philips patient capnography monitors. Philips Corporation has also planned to integrate Masimo measurement technologies with IntelliVue MX-Series multi-parameter monitors that help assess patients’ cerebral oximetry and ventilation status.
- To include Masimo Brain monitoring and chronography technology in capnography monitoring devices, Masimo Corporation entered into a licensing agreement with Dräger AG & Co. In December 2019.
- A Microstream capnography, multi-center study to identify and record a total number of people at high risk of opioid-induced respiratory depression (OIRD) was carried out by Medtronic plc. It announced the preliminary results of this respiratory compromise assessment in February 2019.